Global Stented Biological Valve Market Growth 2025-2031

Report ID: 3018553 | Published Date: Jan 2026 | No. of Page: 108 | Base Year: 2025 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

The global Stented Biological Valve market size is predicted to grow from US$ 3139 million in 2025 to US$ 4480 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Market Overview:

Stented biological valves are among the most commonly used valves in heart valve replacement surgeries. They are widely used due to their natural function, low risk of thromboembolic events, and favorable clinical outcomes. The addition of a stent allows for easier implantation, particularly in older patients and those undergoing transcatheter procedures.

Market Drivers:

  • Preference for biological valves over mechanical valves due to their natural function and reduced need for anticoagulation.
  • Increasing adoption of minimally invasive approaches like TAVR, where stented biological valves are often preferred.
  • Aging populations and the rising incidence of valvular heart disease.

Market Opportunities:

  • Expanding indications for the use of stented biological valves in various procedures, particularly in lower-risk patient populations.
  • Research into improving the longevity and anti-calcification properties of stented valves.

Market Limitations:

  • Limited durability compared to mechanical valves, which may require reoperation in younger patients.
  • Concerns about the risk of degeneration and calcification, particularly in patients under 65 years old.

Market Trends:

  • Greater adoption of TAVR procedures, leading to a rise in the use of stented biological valves.
  • Ongoing improvements in the durability and biocompatibility of stented biological valves.

Segmentation by Type:

  • Surgical Valve
  • Interventional Valve

Segmentation by Application:

  • Hospital
  • Clinic
  • Other

Market by Region:

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company's Coverage:

  • Medtronic
  • Edwards Lifesciences
  • St. Jude Medical
  • Meril Life Sciences
  • Boston Scientific
  • Labor
  • Abbott
  • Colibri Heart Valve
  • Balance Medical
  • Venus Medtech
  • Suzhou Jiecheng Medical Technology

Key Questions Addressed in this Report:

  • What is the 10-year outlook for the global Stented Biological Valve market?
  • What factors are driving Stented Biological Valve market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Stented Biological Valve market opportunities vary by end market size?
  • How does Stented Biological Valve break out by Type, by Application?
Frequently Asked Questions
Stented Biological Valve report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Stented Biological Valve report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Stented Biological Valve report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports